IMARC Group has recently released a new research study titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
How big is the point-of-care diagnostics market?
The global point-of-care diagnostics market size reached US$ 45.0 Billion in 2022 and the market to reach US$ 75.5 Billion by 2028, exhibiting a CAGR of 8.96% during 2023-2028.
Industry Overview:
Point-of-care diagnostics refer to medical testing that occurs at or near the site of patient care, rather than in a traditional laboratory setting. These diagnostics offer quick, real-time results, enabling healthcare providers to make immediate and informed decisions regarding patient treatment. The ease of use is a distinguishing feature; these tests often require just a small sample of blood, saliva, or urine, and sometimes deliver results within minutes. Various types of point-of-care diagnostics are available, including blood glucose monitors, pregnancy tests, and rapid infectious disease tests, among others. Advanced versions incorporate digital connectivity, offering seamless data transfer to healthcare systems for comprehensive monitoring.
Request to Get the Sample Report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample
Point-of-Care Diagnostics Market Trends and Growth Drivers:
The growing focus on personalized medicine and the need for rapid diagnostics, particularly in time-sensitive situations like infectious disease outbreaks, are significant factors driving the global point-of-care diagnostics market. Innovations in biotechnology have led to the development of more accurate, reliable, and quicker point-of-care tests, thus propelling market growth. Additionally, the increasing prevalence of chronic diseases requiring regular monitoring, like diabetes and cardiovascular diseases, adds to the demand. Sustainability concerns and the need to reduce medical waste have also catalyzed the development of eco-friendly, reusable point-of-care diagnostic devices, positively affecting market outlook. Similarly, the rise of telemedicine and remote healthcare, accelerated by the COVID-19 pandemic, has made these diagnostics more relevant than ever. The convenience of at-home testing, coupled with the growth of e-commerce platforms specializing in medical supplies, has made point-of-care diagnostics more accessible to a wider audience.
Other influencing factors include growing public awareness of the importance of early diagnosis for effective treatment and the increasing investment in healthcare infrastructure globally.
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- Pts Diagnostics
- Qiagen
- Siemens
- Trinity Biotech
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/request?type=report&id=2113&flag=C
Point-of-Care Diagnostics Market Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Breakup by Platform:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Breakup by Prescription Mode:
- Prescription-Based Testing
- OTC Testing
Breakup by End-User:
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com
